Dependent Variables | Predictors | β [95% CI β] | P-value |
---|---|---|---|
Serum zinc level | Problematic alcohol use | -2.7[−4.01 - -1.5] | < 0.01 |
Female sex | -1.28 [−2.5 - -0.07] | 0.04 | |
DDS | 9.75 [7.71–11.79] | < 0.01 | |
High family size | −1.63 [−2.68 - -0.58] | < 0.01 | |
HIV | −2.95 [−4.97 - -0.92] | < 0.01 | |
Age | −0.043 [−0.08 - -0.01] | 0.01 | |
Anti-leishmaniasis treatments | 0.09 [−0.3–0.48] | 0.66 | |
Iron | Alcohol | 7.6 [5.86–9.35] | < 0.01 |
Chronic diseases | −7.44 [−9.75 - -5.13] | 0.01 | |
Malaria | −12.69 [−14.53 - -10.87] | < 0.01 | |
Hookworm | −4.48 [−6.82 - -2.14] | < 0.01 | |
High family size | −5.14 [−7.01 - -3.28] | < 0.01 | |
HIV | −5.51 [−8.23 - -2.78] | < 0.01 | |
Age | 0.11 [0.07–0.15] | < 0.01 | |
MUAC | 0.75 [0.21–1.29] | < 0.01 | |
Anti-leishmaniasis treatments | 0.67 [0.08–1.27] | 0.02 | |
Serum Selenium | HIV | −18.1 [−20.63 - -15.58] | < 0.01 |
High family size | −11.36 [− 13.02 - -9.7] | < 0.01 | |
Anti-leishmaniasis treatments | 3.04 [2.32–3.76] | < 0.01 | |
Iodine | Malaria | −3.78 [−6.16 - -1.39] | < 0.01 |
DDS | 25 .84 [22.57–29.1] | < 0.01 | |
Smoking | −12.34 [− 15.98 - -8.7] | < 0.01 | |
HIV | −38.02 [−41.98 - -34.06] | < 0.01 | |
Chronic illness | −5.14 [−7.82 - -2.46] | < 0.01 | |
Regular physical exercise | 5.82 [0.39–11.26] | 0.04 | |
Anti-leishmaniasis treatments | 13.67 [13.15–14.2] | < 0.01 | |
Vitamin A | Problematic alcohol use | −1.09 [− 2.01 - -0.17] | 0.02 |
Chronic illness | −2.56 [−3.53 - -1.59] | < 0.01 | |
Urban residence | 0.81 [0.08–1.54] | 0.03 | |
DDS | 1.62 [0.36–2.88] | 0.01 | |
Malaria | −4.8 [−5.91 - -3.85] | < 0.01 | |
High family size | −5.03 [− 5.83 - -4.22] | < 0.01 | |
HIV | −2.89 [−4.44 - -1.34] | < 0.01 | |
Age | 0.09 [0.07–0.12] | < 0.01 | |
MUAC | 0.86 [0.52–1.21] | < 0.01 | |
Anti-leishmaniasis treatments | −0.3 [− 0.62 - -0.17] | 0.06 | |
Vitamin D | BMI | 1.52 [0.42–2.6] | < 0.01 |
DDS | 16.24 [14.89–17.58] | < 0.01 | |
Malaria | −0.61 [−3.37 - -3.37] | < 0.01 | |
Hookworm | −3.94 [−5.46 - -2.41] | < 0.01 | |
High family size | −1.15 [−2.03 - -0.28] | < 0.01 | |
HIV | −9.43 [− 10.92 - -7.94] | < 0.01 | |
Age | 0.03 [0.001–0.06] | 0.04 | |
Anti-leishmaniasis treatments | −0.94 [−1.25 - -0.63] | < 0.01 |